Furthermore, fatty-acid binding protein 4 (FABP4), which is produced by adipocytes and macrophages, was elevated in NASH patients, and served as a biomarker to identify progression in NAFLD [206,207]. The gene discussed is FABP4; the disease is metabolic dysfunction-associated steatohepatitis.